A report on the clinical trial with carbutamide is presented. The comparative effects of different oral agents on diabetes mellitus is discussed. Nadisan is one of the most effective oral hypoglycaemic drugs if used on properly selected cases. It is safe with clinical dosage recommended and has the advantage of being economic and easy for administration on account of its long acting response.